tradingkey.logo

ImageneBio Ord Shs

IMA
6.180USD
-0.010-0.16%
Close 12/19, 16:00ETQuotes delayed by 15 min
69.10MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of ImageneBio Ord Shs to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
---26.64M
Net income from continuing operations
---27.05M
Other non-cash items
---226.00K
Change in working capital
---13.34M
-Change in prepaid expenses
---2.99M
-Change in other current assets
---2.22M
-Change in other current liabilities
---666.00K
Cash from non-recurring investing activities
Cash from operating activities
---26.64M
Investing cash flow
Net cash from continuing investing activities
--0.00
Net cash flow from disposal of fixed assets
--0.00
Net cash flow from investment products
---47.12M
Net cash flow from other investing activities
--15.00M
Cash from non-current investing activities
Net cash flow from investing activities
---37.33M
Financing cash flow
Cash flow from continuous financing activities
--135.47M
Net cash flow from debt Issuance/repayment
--15.00M
Net cash flow from common stock issuance/repurchase
--71.13M
Proceeds from stock option exercised by employees
--45.00K
Net cash flow from other financing activities
--49.29M
Net cash from non-recurrent financing activities
Net cash from financing activities
--135.47M
Net cash flow
Beginning cash balance
--31.02M
Current period cash flow changes
--72.15M
Effect of exchange rate changes
--652.00K
Ending cash balance
--103.16M
Free cash flow
---26.64M
Currency unit
USD
Audit opinions
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI